Pages that link to "Q35794801"
Jump to navigation
Jump to search
The following pages link to Tumor tissue microRNA expression in association with triple-negative breast cancer outcomes (Q35794801):
Displaying 22 items.
- MiRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast Cancer (Q26775086) (← links)
- MicroRNAs in the prognosis of triple-negative breast cancer: A systematic review and meta-analysis (Q33765619) (← links)
- Downregulation of microRNA-27b-3p enhances tamoxifen resistance in breast cancer by increasing NR5A2 and CREB1 expression (Q36181081) (← links)
- miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer. (Q36191985) (← links)
- Identification of MicroRNAs as Breast Cancer Prognosis Markers through the Cancer Genome Atlas (Q36222283) (← links)
- MiRNAs Predict the Prognosis of Patients with Triple Negative Breast Cancer: A Meta-Analysis (Q36249008) (← links)
- miR-16-5p Is a Stably-Expressed Housekeeping MicroRNA in Breast Cancer Tissues from Primary Tumors and from Metastatic Sites (Q36666943) (← links)
- MicroRNA analysis of breast ductal fluid in breast cancer patients (Q36734184) (← links)
- miR-655 suppresses epithelial-to-mesenchymal transition by targeting Prrx1 in triple-negative breast cancer (Q36797492) (← links)
- Noncoding RNAs in breast cancer (Q36935047) (← links)
- Serum microRNA profiles as diagnostic biomarkers for HBV-positive hepatocellular carcinoma (Q40392279) (← links)
- miR-218-5p restores sensitivity to gemcitabine through PRKCE/MDR1 axis in gallbladder cancer. (Q41082524) (← links)
- ADAM12-L confers acquired 5-fluorouracil resistance in breast cancer cells (Q41548025) (← links)
- PTIP promotes recurrence and metastasis of hepatocellular carcinoma by regulating epithelial-mesenchymal transition (Q41709626) (← links)
- MiR-27b directly targets Rab3D to inhibit the malignant phenotype in colorectal cancer (Q50105595) (← links)
- Levels of miR-126 and miR-218 are elevated in ductal carcinoma in situ (DCIS) and inhibit malignant potential of DCIS derived cells. (Q55251624) (← links)
- Pre-transplant expressions of microRNAs, comorbidities, and post-transplant mortality (Q57044350) (← links)
- MicroRNA in diagnosis and therapy monitoring of early-stage triple-negative breast cancer (Q58803658) (← links)
- miR-206 Promotes Cancer Progression by Targeting Full-Length Neurokinin-1 Receptor in Breast Cancer (Q90042569) (← links)
- The Multifunction Of miR-218-5p-Cx43 Axis In Breast Cancer (Q90835203) (← links)
- Validation of the four-miRNA biomarker panel MiCaP for prediction of long-term prostate cancer outcome (Q96952267) (← links)
- MicroRNA-27b-3p Promotes Tumor Progression and Metastasis by Inhibiting Peroxisome Proliferator-Activated Receptor Gamma in Triple-Negative Breast Cancer (Q98771278) (← links)